Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cytomegalovirus Prophylaxis”

106 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 106 results

Large-scale testing (Phase 3)Looking for participantsNCT06407232
What this trial is testing

Letermovir (Prevymis) for CMV in Kidney and Pancreas Transplant Recipients

Who this might be right for
Cytomegalovirus InfectionsKidney Transplant InfectionPancreas Transplant
University of Wisconsin, Madison 90
Large-scale testing (Phase 3)Ended earlyNCT05170269
What this trial is testing

Prevention of Maternal-fetal Cytomegalovirus Transmission After Primary Maternal Infection, GW ≤ 14 (PreCyssion)

Who this might be right for
Congenital Cytomegalovirus Infection
Biotest 48
Large-scale testing (Phase 3)Study completedNCT01769170
What this trial is testing

The Safety and Efficacy of CMX001 for the Prevention of CMV Infection in CMV-seropositive HCT Recipients

Who this might be right for
CMV
Jazz Pharmaceuticals 452
Not applicableStudy completedNCT00002299
What this trial is testing

The Safety and Effectiveness of Ganciclovir Plus Interferon Beta in Preventing the Return of Cytomegalovirus (CMV) of the Eyes in Patients With AIDS

Who this might be right for
Cytomegalovirus RetinitisHIV Infections
Hoffmann-La Roche
Not applicableStudy completedNCT00002095
What this trial is testing

A Randomized, Double-Blind Study of the Efficacy and Safety of Oral Ganciclovir for the Prevention of CMV Disease in People Infected With the Human Immunodeficiency Virus

Who this might be right for
Cytomegalovirus InfectionsHIV Infections
Hoffmann-La Roche 700
Not applicableStudy completedNCT00907686
What this trial is testing

TT-CMV Observational Birth Cohort Study

Who this might be right for
Cytomegalovirus Disease
Emory University 600
Not applicableStudy completedNCT00566072
What this trial is testing

The Influence of Intensive Education and Coaching on Compliance for Oral Ganciclovir in the Prophylaxis of CMV: an Open Randomised Trial

Who this might be right for
Cytomegalovirus Infections
University Hospital, Ghent 21
Large-scale testing (Phase 3)Looking for participantsNCT06798909
What this trial is testing

Kidney Transplant Preemptive Therapy or Prophylaxis for CMV Prevention in D+R Recipients

Who this might be right for
Cytomegalovirus (CMV)Kidney Transplant; ComplicationsKidney Diseases
University of California, San Francisco 360
Testing effectiveness (Phase 2)Ended earlyNCT03343600
What this trial is testing

Imatinib for Cytomegalovirus Prophylaxis and Treatment After Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Patients Who Have Received Allo-HSCT
National Taiwan University Hospital 5
Not applicableActive Not RecruitingNCT01199562
What this trial is testing

Infection Prophylaxis and Management in Treating Cytomegalovirus (CMV) Infection in Patients With Hematologic Malignancies Previously Treated With Donor Stem Cell Transplant

Who this might be right for
Hematopoietic/Lymphoid CancerAccelerated Phase Chronic Myelogenous LeukemiaAcute Undifferentiated Leukemia+151 more
City of Hope Medical Center 153
Large-scale testing (Phase 3)Study completedNCT03930615
What this trial is testing

Extension of Letermovir (LET) From Day 100 to Day 200 Post-transplant for the Prevention of Cytomegalovirus (CMV) Infection in Hematopoietic Stem Cell Transplant (HSCT) Participants (MK-8228-040)

Who this might be right for
Cytomegalovirus Infection
Merck Sharp & Dohme LLC 220
Not applicableLooking for participantsNCT06441669
What this trial is testing

Effect of Letermovir Prophylaxis on CMV-specific Immune Reconstitution Post UCBT

Who this might be right for
Cytomegalovirus Infection Reactivation
Anhui Provincial Hospital 60
Testing effectiveness (Phase 2)Looking for participantsNCT06066957
What this trial is testing

Open Label Trial of Oral Letermovir for CMV Prophylaxis in Thoracic Transplant Recipients

Who this might be right for
Cytomegalovirus InfectionsTransplant-Related Disorder
University of Pennsylvania 80
Testing effectiveness (Phase 2)Study completedNCT02227641
What this trial is testing

Preventative/Preemptive Adoptive Transfer of Peptide Stimulated CMV/EBV Specific T-cells in Patients After Allogeneic Stem Cell Transplantation

Who this might be right for
Patients Undergoing Allogeneic Stem Cell Transplantation
University of Erlangen-Nürnberg Medical School 50
Large-scale testing (Phase 3)Study completedNCT03123627
What this trial is testing

Randomized Clinical Trial, Open, Multicenter Parallel, no Suspension Inferiority Prophylactic Treatment With Valganciclovir in Kidney Transplant CMV-seropositive Cellular Immunity to Develop CD8 + CMV-specific Treatment After Induction Thymoglobulin.

Who this might be right for
Kidney Transplant Infection
Maimónides Biomedical Research Institute of Córdoba 150
Large-scale testing (Phase 3)Looking for participantsNCT05711667
What this trial is testing

The Drug Letermovir as Prevention of Cytomegalovirus Infection After Stem Cell Transplant in Pediatric Patients

Who this might be right for
Hematopoietic and Lymphoid Cell NeoplasmMalignant Solid Neoplasm
Children's Oncology Group 105
Testing effectiveness (Phase 2)Ended earlyNCT05370976
What this trial is testing

Efficacy and Safety of Cytotect®CP, Hyperimmune Anti-CMV IVIg as CMV Prophylaxis in Patients Developing Acute Grade II-IV GVHD After Allogeneic Hematopoietic Cell Transplantation.

Who this might be right for
Cytomegalovirus Infections
University Hospital, Lille 2
Testing effectiveness (Phase 2)Study completedNCT03486834
What this trial is testing

V160 2-Dose and 3-Dose Regimens in Healthy Cytomegalovirus (CMV) Seronegative Females (V160-002)

Who this might be right for
Cytomegalovirus (CMV) Infections
Merck Sharp & Dohme LLC 2,200
Early research (Phase 1)Study completedNCT00673868
What this trial is testing

Cytomegalovirus (CMV) Specific Cytotoxic T Lymphocytes (CTL) When Used for Prophylaxis Against CMV in Recipients of Allogeneic, T Cell Depleted Stem Cell Transplants

Who this might be right for
Cytomegalovirus Infections
Milton S. Hershey Medical Center 2
Testing effectiveness (Phase 2)Study completedNCT04934527
What this trial is testing

Association of T Gamma Delta-CD16+ Cells and Anti-CMV Immunoglobulins in the Prevention of CMV Infection

Who this might be right for
Kidney TransplantationCMV Infection
University Hospital, Bordeaux 42
Load More Results